Education
About Us
Working with TipRanks
Follow Us
Anika Therapeutics, Inc. (ANIK)
:ANIK
Earnings Data
Report Date
Mar 10, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.13Last Year’s EPS
-0.03Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted strong growth in the Commercial Channel, significant progress in regulatory submissions, and improved cost management. However, these positives were offset by revenue declines in key segments and challenges with pricing pressure and study results.Company Guidance
Commercial Channel Revenue Growth
Commercial Channel revenue grew 22%, driven by strong Integrity growth, Hyalofast expansion outside the U.S., and international growth in OA Pain Management.
Integrity Procedures and Growth
Integrity procedures in the U.S. grew for the sixth consecutive quarter, driving Regenerative Solutions growth of 25% year-over-year. The number of surgeon users increased to nearly 300.
Successful Hyalofast PMA Submission
The third and final PMA module for Hyalofast was submitted to the FDA on October 31st, marking a major milestone in the U.S. regulatory pathway.
Cingal Milestone and Progress
Surpassed sales of 1 million Cingal injections since 2016 launch. Progress made towards U.S. NDA submission with successful completion of the first toxicity study.
Cost Structure Improvements
SG&A expenses down 12% year-over-year and overall operating expenses down 3%, leading to improved profitability and free cash flow.
ANIK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ANIK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $9.63 | $9.85 | +2.28% |
Jul 30, 2025 | $11.16 | $8.10 | -27.42% |
May 09, 2025 | $14.74 | $11.64 | -21.03% |
Mar 12, 2025 | $17.11 | $15.21 | -11.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Anika Therapeutics, Inc. (ANIK) report earnings?
Anika Therapeutics, Inc. (ANIK) is schdueled to report earning on Mar 10, 2026, After Close (Confirmed).
What is Anika Therapeutics, Inc. (ANIK) earnings time?
Anika Therapeutics, Inc. (ANIK) earnings time is at Mar 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ANIK EPS forecast?
ANIK EPS forecast for the fiscal quarter 2025 (Q4) is -0.13.